Angiotensin-(1-7): Pharmacology and new perspectives in cardiovascular treatments

Cardiovascular Drug Reviews

Volumn 25, Issue 2, 2007, Pages 162-174

  Trask, Aaron J ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Angiotensin (1 7); Cancer; Cardiac arrhythmias; Cardiac hypertrophy; Heart failure; Hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 2; IRBESARTAN; LISINOPRIL; LOSARTAN; MEMBRANE METALLOENDOPEPTIDASE; PROLYL ENDOPEPTIDASE; THIMET OLIGOPEPTIDASE; UNCLASSIFIED DRUG;

BRAIN; BREAST CANCER; CANCER; CLINICAL TRIAL; CYTOPENIA; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HYPERTENSION; KIDNEY; KIDNEY DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; UNSPECIFIED SIDE EFFECT; VASODILATATION;

ANGIOTENSIN I; ANIMALS; ANTIHYPERTENSIVE AGENTS; BRAIN; CARDIOVASCULAR DISEASES; HEART; HUMANS; KIDNEY; PEPTIDE FRAGMENTS; RENIN-ANGIOTENSIN SYSTEM;

EID: 34447120723     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2007.00012.x     Document Type: Review

References (85)

1. Allred AJ, Diz DI, Ferrario CM, Chappell MC (2000) Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol 279 : F841 F850.
2. Averill DB, Ishiyama Y, Chappell MC, Ferrario CM (2003) Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation 108 : 2141 2146.
3. Benter IF, Diz DI, Ferrario CM (1995a) Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension 26 : 1138 1144.
4. Benter IF, Ferrario CM, Morris M, Diz DI (1995b) Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 269 : H313 H319.
5. Benter IF, Yousif MH, Anim JT, Cojocel C, Diz DI (2006) Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol 290 : H684 H691.
6. Brosnihan KB, Li P, Ferrario CM (1996) Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27 : 523 528.
7. Burgelova M, Kramer HJ, Teplan V, Thumova M, Cervenka L (2005) Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity. Kidney Int 67 : 1453 1461.
8. Burgelova M, Kramer HJ, Teplan V, Velickova G, Vitko S, Heller J, Maly J, Cervenka L (2002) Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat. Kidney Blood Press Res 25 : 202 210.
9. Campagnole-Santos MJ, Heringer SB, Batista EN, Khosla MC, Santos RA (1992) Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol 263 : R89 R94.
10. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP (2005) Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46 : 937 942.
11. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP (2006) Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart. Life Sci 80 : 264 268.
12. Chappell MC, Allred AJ, Ferrario CM (2001) Pathways of angiotensin-(1-7) metabolism in the kidney. Nephrol Dial Transplant 16 (Suppl 1 22 26.
13. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM (1989) Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 264 : 16518 16523.
14. Chappell MC, Gomez MN, Pirro NT, Ferrario CM (2000) Release of angiotensin-(1-7) from the rat hindlimb: Influence of angiotensin-converting enzyme inhibition. Hypertension 35 : 348 352.
15. Chappell MC, Pirro NT, Sykes A, Ferrario CM (1998) Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31 : 362 367.
16. Clark MA, Tallant EA, Tommasi E, Bosch S, Diz DI (2003) Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism. J Cardiovasc Pharmacol 41 : 276 283.
17. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 : 822 828.
18. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68 : 450 456.
19. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359 : 995 1003.
20. De Mello WC (2004) Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump. J Renin-Angiotensin-Aldosterone Syst 5 : 203 208.
21. Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdos EG (1998) N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: Angiotensin-(1-7) and keto-ACE. Hypertension 31 : 912 917.
22. DelliPizzi AM, Hilchey SD, Bell-Quilley CP (1994) Natriuretic action of angiotensin(1-7). Br J Pharmacol 111 : 1 3.
23. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87 : E1 E9.
24. Faria-Silva R, Duarte FV, Santos RA (2005) Short-term angiotensin-(1-7) receptor MAS stimulation improves endothelial function in normotensive rats. Hypertension 46 : 948 952.
25. Ferrario CM, Chappell MC, Dean RH, Iyer SN (1998a) Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis. J Am Soc Nephrol 9 : 1716 1722.
26. Ferrario CM, Martell N, Yunis C, Flack JM, Chappell MC, Brosnihan KB, Dean RH, Fernandez A, Novikov SV, Pinillas C, et al. (1998b) Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens 11 : 137 146.
27. Ferrario CM, Trask AJ, Jessup JA (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289 : H2281 H2290.
28. Ferreira AJ, Santos RA, Almeida AP (2001) Angiotensin-(1-7): Cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38 : 665 668.
29. Ferreira AJ, Santos RA, Almeida AP (2002) Angiotensin-(1-7) improves the postischemic function in isolated perfused rat hearts. Braz J Med Biol Res 35 : 1083 1090.
30. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA (1996) Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28 : 104 108.
31. Gallagher PE, Tallant EA (2004) Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25 : 2045 2052.
32. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich M (2006a) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292 : H736 H742.
33. Grobe JL, Mecca AP, Mao H, Katovich MJ (2006b) Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290 : H2417 H2423.
34. Handa RK, Ferrario CM, Strandhoy JW (1996) Renal actions of angiotensin-(1-7): In vivo and in vitro studies. Am J Physiol 270 : F141 F147.
35. Heller J, Kramer HJ, Maly J, Cervenka L, Horacek V (2000) Effect of intrarenal infusion of angiotensin-(1-7) in the dog. Kidney Blood Press Res 23 : 89 94.
36. Hellner K, Walther T, Schubert M, Albrecht D (2005) Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 29 : 427 435.
37. HOPE Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355 : 253 259.
38. Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ, Ferrario CM, Raizada MK (2005) Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp Physiol 90 : 783 790.
39. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM (2004) Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43 : 970 976.
40. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX, Greenberg BH (2005) Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289 : H2356 H2363.
41. Kato T, Okada M, Nagatsu T (1980) Distribution of postproline cleaving enzyme in human brain and the peripheral tissues. Mol Cell Biochem 32 : 117 121.
42. Koida M, Walter R (1976) Postproline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J Biol Chem 251 : 7593 7599.
43. Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, Gembardt F, Kellett E, Martini L, Vanderheyden P, et al. (2005) G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111 : 1806 1813.
44. Langeveld B, van Gilst WH, Tio RA, Zijlstra F, Roks AJ (2005) Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat. Hypertension 45 : 138 141.
45. Lemos VS, Silva DMR, Walther T, Alenina N, Bader M, Santos RAS (2005) The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice. J Cardiovasc Pharmacol 46 : 274 279.
46. Li P, Chappell MC, Ferrario CM, Brosnihan KB (1997) Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29 : 394 400.
47. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, van Gilst WH (2002) Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105 : 1548 1550.
48. Menon J, Sato-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE (2007) Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res 67 (6 2809 2815.
49. Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB (2002) Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 18 : 239 245.
50. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH (1995) Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 25 : 796 802.
51. Oliveira DR, Santos RA, Santos GF, Khosla M, Campagnole-Santos MJ (1996) Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension 27 : 1284 1290.
52. Pantoja DS, Tallant EA, Gallagher PE (2004) Inhibition of human breast cancer cell growth by angiotensin-(1-7). Proc Am Assoc Cancer Res 45.
53. Paula RD, Lima CV, Khosla MC, Santos RA (1995) Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 26 : 1154 1159.
54. Porsti I, Bara AT, Busse R, Hecker M (1994) Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 111 : 652 654.
55. Qadri F, Wolf A, Waldmann T, Rascher W, Unger T (1998) Sensitivity of hypothalamic paraventricular nucleus to C- and N-terminal angiotensin fragments: Vasopressin release and drinking. J Neuroendocrinol 10 : 275 281.
56. Rodgers KE, Oliver J, diZerega GS (2006) Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother Pharmacol 57 : 559 568.
57. Sakima A, Averill DB, Gallagher PE, Kasper SO, Tommasi EN, Ferrario CM, Diz DI (2005) Impaired heart rate baroreflex in older rats: Role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension 46 : 333 340.
58. Santos RA, Brosnihan KB, Jacobsen DW, DiCorleto PE, Ferrario CM (1992) Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 19 : II56 II61.
59. Santos RA, Castro CH, Gava E, Pinheiro SV, Almeida AP, Paula RD, Cruz JS, Ramos AS, Rosa KT, Irigoyen MC, et al. (2006) Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice. Hypertension 47 : 996 1002.
60. Santos R, Ferreira AJ (2006) Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist. Cardiovasc Drug Rev 24 : 239 246.
61. Santos RA, Simoes E, Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100 : 8258 8263.
62. Schiavone MT, Santos RA, Brosnihan KB, Khosla MC, Ferrario CM (1988) Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 85 : 4095 4098.
63. Schiridler C, Brosnihan KB, Ferrario CM, Bramlage P, Maywald U, Koch R, Oertel R, Kirch W (2007) Comparison of inhibitory effects of irbesartan and atorrastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects. J Clin Pharmacol 47(1) : 112 120.
64. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, Rose JC, Chappell MC (2007) Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: Evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292 : F82 F91.
65. Silva DM, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RA, Lemos VS (2006) Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28 (3 702 707.
66. Strawn WB, Ferrario CM, Tallant EA (1999) Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33 : 207 211.
67. Su EJ, Lombardi DM, Siegal J, Schwartz SM (1998) Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure. Hypertension 31 : 1331 1337.
68. Tallant EA, Clark MA (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42 : 574 579.
69. Tallant EA, Ferrario CM, Gallagher PE (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 289 : H1560 H1566.
70. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM (1997) Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 29 : 388 393.
71. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275 : 33238 33243.
72. Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, Ryan D, Fisher M, Williams D, Dales NA, et al. (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279 : 17996 18007.
73. Trask AJ, Averill DB, Ganten D, Chappell MC, Ferrario CM (2007) Primary role of angiotensin converting enzyme 2 in cardiac production of angiotensin-(1-7) in transgenic ren-2 hypertensive rats. Am J Physiol Heart Circ Physiol 292 : H3019 H3024.
74. Valdes G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM, Brosnihan KB (2001) Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine 16 : 117 122.
75. Valdes G, Neves LA, Anton L, Corthorn J, Chacon C, Germain AM, Merrill DC, Ferrario CM, Sarao R, Penninger J, et al. (2006) Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta 27 : 200 207.
76. Vallon V, Heyne N, Richter K, Khosla MC, Fechter K (1998) [7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat. J Cardiovasc Pharmacol 32 : 164 167.
77. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277 : 14838 14843.
78. Wackenfors A, Pantev E, Emilson M, Edvinsson L, Malmsjo M (2004) Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: Effects of heart failure and age. Basic Clin Pharmacol Toxicol 95 : 266 272.
79. Walter R, Shlank H, Glass JD, Schwartz IL, Kerenyi TD (1971) Leucylglycinamide released from oxytocin by human uterine enzyme. Science 173 : 827 829.
80. Wang LJ, He JG, Ma H, Cai YM, Liao XX, Zeng WT, Liu J, Wang LC (2005) Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats. Di Yi Jun Yi Da Xue Xue Bao 25 : 481 487.
81. Wei CC, Ferrario CM, Brosnihan KB, Farrell DM, Bradley WE, Jaffa AA, Dell'Italia LJ (2002) Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo. J Pharmacol Exp Ther 300 : 324 329.
82. Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM (1998) Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 32 : 496 502.
83. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM (1992) In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 19 : 692 696.
84. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC (2003a) Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: Evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 108 : 1707 1712.
85. Zisman LS, Meixell GE, Bristow MR, Canver CC (2003b) Angiotensin-(1-7) formation in the intact human heart: In vivo dependence on angiotensin II as substrate. Circulation 108 : 1679 1681.